Capecitabine is Used for treating tumors. It was first introduced by Cheplapharm Arzneimittel Gmbh in its drug Xeloda on Apr 30, 1998. 15 different companies have introduced drugs containing Capecitabine.
Capecitabine Patents
Given below is the list of patents protecting Capecitabine, along
with the drug name that holds that patent and the company name owning that
drug.
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List
Capecitabine Generic API Manufacturers
Several generic applications have been filed for Capecitabine. The first generic version for Capecitabine was by Teva Pharmaceuticals Usa Inc and was approved on Sep 16, 2013. And the latest generic version is by Hetero Labs Ltd Unit V and was approved on Mar 5, 2024.
Given below is the list of companies who have filed for
Capecitabine generic, along with the locations of their manufacturing plants worldwide.
1. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 2 different strengths of generic version for Capecitabine. Given below are the
details of the strengths of this generic introduced by
Accord Hlthcare.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
150MG
tablet
Prescription
ORAL
AB
Apr 23, 2015
500MG
tablet
Prescription
ORAL
AB
Apr 23, 2015
2. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 2 different strengths of generic version for Capecitabine. Given below are the
details of the strengths of this generic introduced by
Alkem Labs Ltd.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
150MG
tablet
Prescription
ORAL
AB
Nov 24, 2017
500MG
tablet
Prescription
ORAL
AB
Nov 24, 2017
3. AMNEAL PHARMS
Amneal Pharmaceuticals has filed for 2 different strengths of generic version for Capecitabine. Given below are the
details of the strengths of this generic introduced by
Amneal Pharms.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
500MG
tablet
Discontinued
ORAL
N/A
Feb 28, 2017
150MG
tablet
Discontinued
ORAL
N/A
Feb 28, 2017
4. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 2 different strengths of generic version for Capecitabine. Given below are the
details of the strengths of this generic introduced by
Dr Reddys.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
500MG
tablet
Prescription
ORAL
AB
Dec 4, 2020
150MG
tablet
Prescription
ORAL
AB
Dec 4, 2020
5. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 2 different strengths of generic version for Capecitabine. Given below are the
details of the strengths of this generic introduced by
Eugia Pharma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
500MG
tablet
Prescription
ORAL
AB
Apr 17, 2018
150MG
tablet
Prescription
ORAL
AB
Apr 17, 2018
Manufacturing Plant Locations
New
Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.
Country
City
Firm Name
India
Riico Industrial Area
EUGIA Pharma Specialities Limited
Pashamylaram
Eugia Pharma Specialities Limited
Medchal-Malkajgiri District
EUGIA Pharma Specialities Limited
6. HETERO LABS LTD V
Hetero Labs Ltd Unit V has filed for 2 different strengths of generic version for Capecitabine. Given below are the
details of the strengths of this generic introduced by
Hetero Labs Ltd V.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
150MG
tablet
Prescription
ORAL
AB
Mar 5, 2024
500MG
tablet
Prescription
ORAL
AB
Mar 5, 2024
7. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Capecitabine. Given below are the
details of the strengths of this generic introduced by
Hikma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
150MG
tablet
Discontinued
ORAL
N/A
Jul 14, 2016
500MG
tablet
Discontinued
ORAL
N/A
Jul 14, 2016
Manufacturing Plant Locations
New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
Country
City
Firm Name
United States
Dayton
Hikma Injectables USA Inc
Cherry Hill
Hikma Pharmaceuticals USA Inc.
Eatontown
Hikma Pharmaceuticals USA, Inc.
Carlsbad
Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Portugal
Terrugem Snt
Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman
Hikma Pharmaceuticals LLC
8. MSN
Msn Laboratories Private Ltd has filed for 2 different strengths of generic version for Capecitabine. Given below are the
details of the strengths of this generic introduced by
Msn.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
150MG
tablet
Prescription
ORAL
AB
Jul 2, 2018
500MG
tablet
Prescription
ORAL
AB
Jul 2, 2018
Manufacturing Plant Locations
New
Msn's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Msn as present at those locations.
Reliance Life Sciences Pvt Ltd has filed for 2 different strengths of generic version for Capecitabine. Given below are the
details of the strengths of this generic introduced by
Reliance Life.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
150MG
tablet
Prescription
ORAL
AB
Apr 27, 2020
500MG
tablet
Prescription
ORAL
AB
Apr 27, 2020
Manufacturing Plant Locations
New
Reliance Life's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Reliance Life as present at those locations.
Country
City
Firm Name
India
Navi Mumbai
Reliance Life Sciences Private Limited
10. RISING
Rising Pharma Holding Inc has filed for 2 different strengths of generic version for Capecitabine. Given below are the
details of the strengths of this generic introduced by
Rising.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
150MG
tablet
Prescription
ORAL
AB
Aug 8, 2014
500MG
tablet
Prescription
ORAL
AB
Aug 8, 2014
Manufacturing Plant Locations
New
Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.
Country
City
Firm Name
United States
Phoenix
Rising Sun Farms Inc
Fort Bragg
Rising Tide Sea Vegetables
Saddle Brook
Rising Pharmaceuticals, Inc.
Decatur
Rising Pharma Holdings, Inc
Livingston
Risingsun Iodine Products Corp.
East Brunswick
Rising Pharma Holding, Inc.
Mount Morris
Rising Creek Bakery LLC
Rising Sun
Rising Sun Veterinary Clinic
Flagstaff
Rising High Enterprises, LLC (DBA RisingHy)
Mexico
Pueblo San Clemente
RISING FARMS SAPI DE CV
India
Ahmedabad
Rising Retina Clinic
11. SHILPA
Shilpa Medicare Ltd has filed for 2 different strengths of generic version for Capecitabine. Given below are the
details of the strengths of this generic introduced by
Shilpa.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
500MG
tablet
Prescription
ORAL
AB
Dec 12, 2016
150MG
tablet
Prescription
ORAL
AB
Dec 12, 2016
Manufacturing Plant Locations
New
Shilpa's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Shilpa as present at those locations.
Country
City
Firm Name
United States
Minneapolis
Shilpa Gupta
India
Bengaluru
Shilpa Medicare Limited
Hyderbad
Shilpa Medicare Limited
Polepally, Jadcherla
Shilpa Medicare Limited
Chicksugur, Raichur
Shilpa Pharma Lifesciences Limited
Hyderabad
Shilpa Medicare Limited
12. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Capecitabine. Given below are the
details of the strengths of this generic introduced by
Sun Pharm.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
150MG
tablet
Discontinued
ORAL
N/A
Jun 21, 2019
500MG
tablet
Discontinued
ORAL
N/A
Jun 21, 2019
Manufacturing Plant Locations
New
Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.
Country
City
Firm Name
United States
Lexington
Sun Pharmaceutical Industries Inc
Princeton
SUN PHARMACEUTICAL INDUSTRIES INC
Billerica
Sun Pharmaceutical Industries, Inc.
India
Vadodara
Sun Pharmaceutical Industries Ltd.
Vadodara
Sun Pharmaceutical Industries Ltd
Vadodara
Sun Pharmaceutical Industries Limited - Karkhadi
Halol
Sun Pharmaceutical Industries Ltd.
New Delhi
Sun Pharmaceutical Industries Limited
Punjab
Sun Pharmaceutical Industries, Inc.
Mohali
Sun Pharmaceutical Industries Limited
Gurugram
Sun Pharmaceutical Industries Limited (prev. Ranbaxy)
Bharuch
Sun Pharmaceutical Industries Ltd
Malanpur, Bhind (District)
Sun Pharmaceutical Industries Limited
Ahmednagar
Sun Pharmaceutical Industries Limited
Kanchipuram
Sun Pharmaceutical Industries Limited- Madhuranthagam
Dadra
Sun Pharmaceutical Industries Limited
Baruch
Sun Pharmaceutical Industries Ltd.
13. TEVA PHARMS USA
Teva Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Capecitabine. Given below are the
details of the strengths of this generic introduced by
Teva Pharms Usa.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
150MG
tablet
Prescription
ORAL
AB
Sep 16, 2013
500MG
tablet
Prescription
ORAL
AB
Sep 16, 2013
14. TEYRO LABS
Teyro Labs Private Ltd has filed for 2 different strengths of generic version for Capecitabine. Given below are the
details of the strengths of this generic introduced by
Teyro Labs.
